Our aims
We are working to optimise the treatment of common respiratory and fungal diseases by applying a P4 approach. Our research:
- Builds a better understanding of the underlying causes of these conditions
- Develops blood and sputum tests, as well as biomarkers in breath, which detect and more accurately characterise respiratory disease and infection to enable an earlier and more personalised approach to treatment
- Tests new drug compounds aimed at novel targets to cure or improve serious lung diseases and minimise symptoms